SCHEMBL11575815

SCHEMBL11575815

COc1ccc(NC(=O)c2ccc(Cl)c(C)c2)cc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.53
RAB9A P51151 10/20 0.53
SMN1; SMN2 Q16637 9/20 0.53
KDM4E B2RXH2 4/20 0.53
TP53 P04637 3/20 0.53
ESR1 P03372 1/20 0.53
ESR2 Q92731 1/20 0.53
MAPT P10636 6/20 0.52
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
MAOB P27338 4/20 0.52
HSD17B10 Q99714 1/20 0.52
ALDH1A1 P00352 2/20 0.50
PKM P14618 1/20 0.50
GLA P06280 1/20 0.50
MAPK14 Q16539 1/20 0.49
MAOA P21397 1/20 0.49
THRB P10828 1/20 0.49
HPGD P15428 1/20 0.49
STAT3 P40763 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6813210 0.90 NPC1 (0.64) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL6813517 0.88 NPC1 (0.55) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL2581955 0.87 NPC1 (0.64) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL29877685 0.85 MAOB (0.58) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL11318579 0.84 NPC1 (0.58) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL6809682 0.83 NPC1 (0.56) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL11693468 0.83 NPC1 (0.60) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL6813395 0.82 HDAC8 (0.64) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL16431269 0.81 GRM5 (0.65) NPC1RAB9ASMN1; SMN2KDM4ETP53
SCHEMBL6787762 0.81 RAB9A (0.62) NPC1RAB9ASMN1; SMN2TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4080321-A COLORFASTNESS HOECHST AKTIENGESELLSCHAFT (DT) 1978-03-21 US disclosed